首页> 外文期刊>International Orthopaedics >Surgical therapy of skeletal complications in multiple myeloma
【24h】

Surgical therapy of skeletal complications in multiple myeloma

机译:多发性骨髓瘤骨骼并发症的外科治疗

获取原文
获取原文并翻译 | 示例
       

摘要

Patients with multiple myeloma are often treated surgically as though they have bone metastases. Due to major differences in oncological therapy and comparatively long survival times these patients should be considered separately. Seventy-five multiple myeloma patients were treated surgically (83 interventions) for skeletal complications of the disease. Location and dissemination, symptoms, method of surgery, complications, recurrence and survival time were evaluated retrospectively. Most of the lesions were in the axial skeleton or the proximal extremities apart from one distal lesion of the fibula, and most surgery was performed in the spine (35 patients). The mean follow-up of patients was 5.4 years (range 1–25 years). Survival proved to be very favourable (37% at five years). Patients with a single bone lesion, a negative bone marrow biopsy, no paraproteinaemia in serum or a Salmon-Durie-stage I had a better survival probability. Surgical treatment in patients with multiple myeloma was mostly limited to a palliative approach but survival time was better (37% at five years) than in patients with metastatic bone disease which has to be considered in their surgical treatment.
机译:多发性骨髓瘤患者通常经过手术治疗就好像有骨转移瘤一样。由于肿瘤治疗方法的重大差异以及相对较长的生存时间,因此应单独考虑这些患者。对75例多发性骨髓瘤患者进行了手术治疗(83次干预),以治疗该疾病的骨骼并发症。回顾性评估其位置和传播,症状,手术方法,并发症,复发和生存时间。大多数病变位于腓骨的一个远端病变处,位于轴向骨骼或近端,并且大多数手术在脊柱进行(35例患者)。患者的平均随访时间为5.4年(范围为1至25年)。生存被证明是非常有利的(五年时为37%)。患有单个骨病变,骨髓活检阴性,血清中无高蛋白血症或Salmon-Durie期I的患者具有更高的生存率。多发性骨髓瘤患者的手术治疗大多仅限于姑息治疗,但其生存时间(5年时为37%)比转移性骨病患者的手术治疗要好得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号